2nd Annual Breast Cancer Symposium: Controversies in Breast Cancer: Increasing or Decreasing?


Friday, September 25, 2020 at 10:00am ET - Saturday, September 26, 2020 at 2:15pm ET



Breast Cancer Health


The keynote address will be given by Dr. Larry Norton, Senior Vice President, Office of the President; Medical Director, Evelyn H. Lauder Breast Center; Norna S. Sarofim Chair in Clinical Oncology; and Associate Cancer Center Director for clinical and translational science; Memorial Sloan Kettering Cancer Center. Faculty will include national thought leaders in breast cancer.

Credits Offered

This event offers 11.0 CME credits to attendees.
Accredited by The University of Chicago Pritzker School of Medicine.

Interested In Attending This Event?

Additional Registration Information:

This conference is complimentary to ALL Nurse Practitioners.  Use code NYOH during registration. 

Jointly provided by New York Oncology Hematology, The University of Chicago Pritzker School of Medicine and myMedEd, Inc.

Advances in breast cancer health have been growing exponentially during the twenty-first century and identification of novel therapeutic strategies has led to improved surgical and radiation outcomes. Actionable targets have identified smarter systemic therapies with improved, disease-free, overall survival benefits. In addition to awareness, addressing the health, emotional, and physical well-being of patients after breast cancer treatment has improved the overall quality of life for the patient and their families. As breast cancer is a multimodal disease, the purpose of this conference is to present the multiple facets that constitute the individual patient’s diagnosis, management, and treatment. The goal of this conference is to educate the medical and global community in a forum to foster communication that will benefit the individual patient as well as the community.

After completing this activity, participants will be able to:

  • Review the modern surgical approaches addressed in the patient encounter

  • Discuss updates in breast cancer imaging for earlier detection

  • Identify therapeutic advances in early and advanced hormone receptor-positive, HER2neu

    overexpressing and triple-negative breast cancer

  • Review advances in radiation therapy and outcomes

  • Identify risk factors and endocrine interventions in patients’ high risk for developing breast


  • Discuss the role of hereditary genetics and the implication to the patient and their families